Understanding GLP-1 Agonists

What are Semaglutide & Tirzepatide?

They are modified molecules our bodies make, called GLP-1 agonists. They work by increasing insulin production and lowering glucagon secretion, as well as targeting areas in the brain that regulate appetite and thirst.

  • Delays how quickly our stomachs digest foods and delays emptying, which in turn creates a feeling of fullness with smaller meal sizes than normal
  • Slows intestinal digestion which makes you feel full longer
  • Lowers blood sugar and reduces the production of sugar in the liver
  • Stimulates insulin secretion by the pancreas

Who is a candidate?

Semaglutide & Trizepatide are indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30kg/m2 or greater. They are also indicated in people with a BMI of at least 25kg/m2 in the presence of at least one weight-related comorbid condition such as high blood pressure, type 2 diabetes, pre-diabetes, obstructive sleep apnea, or high cholesterol. 

What are typical results people experience?

Typical weight loss with semaglutide is 15%-20% of your total body weight in one year and with Tirzepatide it’s 20-25% of your body weight in one year.

What are the most common side effects:

Nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, flatulence (gas buildup), gastroenteritis (an intestinal infection) and gastroesophageal reflux disease (a type of digestive disorder). 


If you have additional questions, please visit our website www.lifegoalswellness.com and select Contact Us or give us a call at 307.215.1580